Bone Metastasis. Patient Management with PET/CT
|
|
- Susan Richards
- 6 years ago
- Views:
Transcription
1 Bone Metastasis Patient Management with PET/CT
2 Bone Metastasis Patient Management with PET/CT OVERVIEW Bone Metastasis is a process in which cancer cells from the original or primary tumor site break away and spread to a bone or bones. This is a result of the tumor cells entering and traveling through the bloodstream or through the lymphatic system. A majority of the cancers cells that break away from a primary tumor will die before spreading to other sites. When cancer spreads to different areas of the body, it is named after the primary tumor site. For example, if a patient has breast cancer that spreads to the bones, it is referred to as breast cancer with bone metastases. 1 Many people with cancer will develop bone metastases during some course of their disease. Common primary tumor sites that can metastasize to the bone include cancers of the breast, prostate, lung, thyroid and kidney. The American Cancer Society estimates that of the 560,000 people who will die of cancer in 2009, approximately 350,000 will have bone metastases. 1 There are two main types of bone metastasis: osteoblastic and osteolytic. Osteoblastic disease occurs when the cancer cells cause increased bone formation resulting in more dense or sclerotic features. It is often associated with prostate cancer tumor types. Osteolytic disease occurs when the cancer cells cause increased bone mineral turnover or resorption resulting in the decrease of the bone density. The weakening of the bone structures results in bone fractures with minimal trauma. Osteolytic disease is often associated with breast cancer tumor types. Most bone metastases will include a mixture of both osteoblastic and osteolytic types as pure bone metastasis is fairly rare. Bone metastasis usually develops in bones located in the body trunk, including the ribs, vertebral spine, sternum and pelvis and can develop in one or numerous areas including the extremities. If the disease has spread to several areas, symptoms can be relieved, but it is hard to cure. 1 In general, metastatic disease can be found by tests either prior to or after the primary cancer has been diagnosed. When metastatic disease is discovered prior to determining the primary tumor site, it is commonly referred to as cancer with an unknown primary. If metastatic disease develops after the primary tumor site has been diagnosed and treated, it is referred to as distant recurrence. 1 Primary bone cancer, which is much different than bone metastases, occurs when the primary cancer originates in the bones. It also occurs less frequently than bone metastases with an estimated 2,500 people being diagnosed and 1,500 people dying from the disease in
3 SYMPTOMS According to The American Cancer Society, symptoms of Bone Metastases can include bone pain that increases in severity over time and tends to be worse at night, chronic bone fractures with minimal trauma, spinal cord compression and hypercalcemia (increased calcium levels in the blood). Hypercalcemia symptoms can include constipation, nausea and dehydration. 1 THE AMERICAN CANCER SOCIETY ESTIMATES IN 2009: (Numbers are approximate) 560,000 people who will die of cancer 350,000 people who have bone metastasis 3 12
4 TREATMENTS TREATMENTS 1 Please note that any information on treatments included herein is not intended as medical advice to replace the expertise and judgement of a cancer care specialist. Also, many treatment options do carry the risk of side effects and should be discussed in detail with cancer care experts. Treatment choices for people with bone metastases depend on many factors including: the primary cancer type, which and how many bones are affected, and any previous treatments. Most treatment regimens are broken down into two ideologies: Treating the primary cancer systemically Systemic Treatments can include: Chemotherapy Hormone Therapy Immunotherapy Radiation Therapy Treating the specific metastatic bone symptoms Treatments can include: Radiopharmaceuticals Help kill cancer cells in the bone structures Assist in relieving bone pain Bisphosphonates Assist in reducing bone pain Assist in slowing down damage to bone from the cancer cells Assist in reducing increased calcium levels Assist in the reduction of bone fractures caused by the cancer Radiation Therapy Preferred choice when the patient has one or two bone metastases present Assist in relieving bone pain Slow down or prevent future bone weakening and/or fracturing Surgery Used to strengthen broken bones that don t heal properly Insert pins, rods, etc. 4 12
5 THE ROLE OF 18F SODIUM FLUORIDE (NAF) PET OR PET/CT IN BONE METASTASIS The injection 18F NaF was approved by the Food and Drug Administration (FDA) in 1972 as a bone imaging agent to defi ne areas of altered osteogenic activity. 2 Clinical studies have suggested that 18F NaF PET or PET/CT imaging can be of assistance in the management of patient care in bone metastases. When compared to traditional Tc-99m Radionuclide Bone imaging: 18F-labeled Sodium Fluoride (NaF) PET is more accurate than 99mTc-diphosphonate SPECT for identifying both malignant and benign lesions of the skeleton. 3 Combining 18F-fl uoride PET with other imaging, such as CT, can improve the specifi city and overall accuracy of skeletal 18F-fl uoride PET imaging. 3 18F PET scans promise improved imaging quality for both benign and malignant bone disease, with a 25% improvement in sensitivity and specifi city over conventional planar and SPECT bone scans. 4 18F PET is more sensitive than Radionuclide Bone imaging (RNB) in detecting osseous lesions. With RNB, sensitivity in detecting osseous metastases is highly dependent on anatomic localization of these lesions, whereas detection rates of osteoblastic and osteolytic metastases are similar. 5 F-18 PET demonstrates a very early bone reaction when small bone marrow metastases are present, allowing accurate detection of breast cancer bone metastases. This accurate detection has a signifi cant effect on clinical management, compared with the effect on management brought about by detection with conventional bone scanning. 6 PET with 18F-fl uoride demonstrates very high uptake in lytic and sclerotic breast cancer metastases
6 PET/CT for BONE METASTASIS Image provided courtesy of Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. Skeletal PET with 18F- Fluoride: applying new technology to an old tracer. Journal of Nuclear Medicine Jan;49(1):
7 18F SODIUM FLUORIDE (NAF) PET OR PET/CT METASTATIC BONE IMAGING TECHNICAL CONSIDERATIONS 8 Patient Preparation No special patient preparation is required Maintain normal diet Ensure hydration - Drink plenty of fl uids prior to their procedure time Take medications as directed by physician Patient Dosage Amount Adult 10 mci dependent on camera manufacturer suggestions Pediatric Range 0.057mCi/kg with a 4mCi maximum Patient Dosage Administration Route Intravenously (IV) PET Image Acquisition Procedure Blood Flow/Blood Pool Images Area of interest should be placed in camera FOV before tracer injection. Scanner acquisition workstation should be setup for proper protocol depending on facility preference. Acquisition should begin immediately after injection of tracer. Delayed Images (Skeletal Phase) Typically occur 60 minutes after tracer injection Range 30 minutes to 4 hours Patient instructed to drink fluids and perform physical activity during uptake period To facilitate clearance of tracer and reduce background activity Facilities should consult with Radiation Safety Offi ce to determine if any patient isolation restrictions are required during the uptake period Patient voids bladder prior to imaging As in Radionuclide Bone Imaging, proper patient positioning is essential for appropriate image quality Patient positioned on table Arms at body side or above head Acquisition protocol similar to FDG Melanoma Protocol Scan range (May require 2 separate acquisitions) From skull vertex to distal extremities including the toes CT scout acquired (similar to FDG PET protocol) CTAC or Transmission Scan acquired (similar to FDG PET protocol) PET emission scan performed 1-5 minutes/bed depending on body habitus, scanner type and/or scanning mode (2D vs. 3D) Post Procedure Patient Instructions Resume normal activities Encourage drinking fl uids. Disclaimer: Please note that this information is provided for educational purposes only. It is not intended to substitute for informed medical advice. The user of this document should not use this information to diagnose or treat a health problem or disease without consulting with a qualifi ed health care provider. 7 12
8 TARGET PHYSICIAN INFORMATION TARGET PHYSICIAN INFORMATION 18F NaF PET imaging program educators and marketers may wish to focus their efforts on physicians who might be expected, in bone metastatic patient care management, to consider referring their patients for a 18F NaF PET or PET/CT scan, where and when appropriate. Medical Oncologists Inform them that 18F NaF PET Bone imaging can be utilized to stage and restage high risk patients suspected or diagnosed with bone metastases. They should utilize 18F NaF Bone imaging scans in the same manner they utilize Tc-99m MDP or HDP Bone Scans. Radiation Oncologists Inform them that 18F NaF PET Bone imaging can be utilized to stage and restage high risk patients suspected or diagnosed with bone metastases. They should utilize 18F NaF Bone imaging scans in the same manner they utilize Tc-99m MDP or HDP Bone Scans. Surgeons Inform them that 18F NaF PET Bone imaging can be utilized to stage and restage high risk patients suspected or diagnosed with bone metastases. They should utilize 18F NaF Bone imaging scans in the same manner they utilize Tc-99m MDP or HDP Bone Scans. Urologists Inform them that 18F NaF Bone imaging can be utilized to stage and restage high risk prostate cancer patients. They should utilize 18F NaF Bone imaging scans in the same manner they utilize Tc-99m MDP or HDP Bone Scans. 8 12
9 GLOSSARY OF TERMS GLOSSARY 99mTc-diphosphonate: a Technetium-based radionuclide complex used for bone scans. A gamma-emitting radionuclide imaging agent used primarily in skeletal scintigraphy. Because of its absorption by a variety of tumors, it is useful for the detection of neoplasms. 9 Accuracy: The ability of an imaging test to correctly diagnose a suspected medical condition. 10 Bisphosphonates: In pharmacology, bisphosphonates (also called diphosphonates) are a class of drugs that prevent the loss of bone mass, and are used to treat osteoporosis, bone metastasis, multiple myeloma and other bone diseases. In radiopharmacy, other bisphosphonates, medronate (R1, R2 = H) and oxidronate (R1 = H, R2 = OH) are mixed with radioactive technetium and injected for imaging bone and detecting bone disease. 9 Bone Metastasis: Bone metastasis is cancer that started in another location (especially breast, lung, prostate, thyroid and kidney), and spread to the bones. Metastases are established when a single tumor cell or a clump of cells gain access to the blood stream, reach the bone marrow through blood vessels in Haversian canals, extravasate, multiply and neovascularize. 11 Chemotherapy: Treatment with drugs that kill cancer cells. 12 Hormone therapy: Treatment that adds, blocks, or removes hormones. To slow or stop the growth of certain cancers (such as prostate and breast cancer), synthetic hormones or other drugs may be given to block the body s natural hormones. Also called endocrine therapy, hormonal therapy, and hormone treatment. 12 Hypercalcemia: Hypercalcemia is the term that refers to elevated levels of calcium in the bloodstream. Malignancies, particularly breast and lung cancer, are a common cause of elevated blood calcium. It is estimated that up to 20% of individuals with cancer will develop hypercalcemia at some point in their disease. 12 Immunotherapy: Treatment to boost or restore the ability of the immune system to fi ght cancer, infections, and other diseases. Also used to lessen certain side effects that may be caused by some cancer treatments. Agents used in immunotherapy include monoclonal antibodies, growth factors, and vaccines. These agents may also have a direct antitumor effect. Also called biological response modifi er therapy, biological therapy, biotherapy, and BRM therapy. 12 Lymphatic System: The tissues and organs that produce, store, and carry white blood cells that fi ght infections and other diseases. This system includes the bone marrow, spleen, thymus, lymph nodes, and lymphatic vessels (a network of thin tubes that carry lymph and white blood cells). Lymphatic vessels branch, like blood vessels, into all the tissues of the body. 12 Lytic Bone Metastasis: Destruction of an area of bone due to disease process, such as cancer. 13 Metastasis: The spread of cancer from one part of the body to another. A tumor formed by cells that have spread is called a metastatic tumor or a metastasis. The metastatic tumor contains cells that are like those in the original (primary) tumor. 12 Neoplasm or neoplastic event: An abnormal mass of tissue that results when cells divide more than they should or do not die when they should. Neoplasms may be benign (not cancer), or malignant (cancer). Also called tumor
10 GLOSSARY OF TERMS Osteoblastic lesion: Osteoblastic lesions occur when the cancer cells cause increased bone formation resulting in more dense or sclerotic features. They are often associated with prostate cancer tumor types. 12 Osteolytic lesion: Osteolytic lesions occur when the cancer cells cause increased bone mineral turnover or resorption resulting in decrease of the bone density. 12 Primary Tumor: The mass of tumor cells at the original site of the neoplastic event. 12 Radiation Therapy: The use of high-energy radiation from x-rays, gamma rays, neutrons, protons, and other sources to kill cancer cells and shrink tumors. Radiation may come from a machine outside the body (external-beam radiation therapy), or it may come from radioactive material placed in the body near cancer cells (internal radiation therapy). Systemic radiation therapy uses a radioactive substance, such as a radiolabeled monoclonal antibody, that travels in the blood to tissues throughout the body. Also called irradiation and radiotherapy. 12 Radionuclide bone imaging: Nuclear imaging method used to evaluate pathological bone metabolism. The method is used for the detection of bone metastases of malignant tumours, osteomyelitis, joint disorders, stress fractures and other disease entities. 14 Radiopharmaceutical: A radioactive drug used to diagnose or treat disease, including cancer. 12 Specificity: The probability that, given the absence of disease, a normal test result excludes disease. 10 Sensitivity: The probability that, given the presence of disease, an abnormal test result indicates the presence of disease. 10 SPECT bone scans: Diagnostic radionuclide scans completed on a single photon emission computed tomography camera. 15 Spinal Cord Compression: Pressure on the spinal cord that may be caused by a tumor, a spinal fracture, or other conditions. 12 Trabeculae: Any of the intersecting osseous bars occurring in bone
11 REIMBURSEMENT & REFERENCES REIMBURSEMENT Please refer to IBA 18F NaF PET Reimbursement Information Sheet, or contact your IBA Molecular Regional Account Executive. REFERENCES 1. American Cancer Society, 2007 Facts, available at: Accessed July 1, Positron Emission Tomography Drug Products; Safety and Effectiveness of Certain PET Drugs for Specifi c Indications (Food & Drug Administration Docket No. OON-0553) Available at: Accessed: Sept. 28, Grant FD, et.al. Skeletal PET with 18F-fl uoride: Applying New Technology to an old Tracer. J Nucl Med 2008 Jan;49(1): Bridges RL, et.al. An Introduction to Na18F Bone Scintigraphy: Basic Principles, Advanced Imaging Concepts and Case Examples. J Nucl Med Tech 2007;35: Schirrmeister H, et.al. Sensitivity in Detecting Osseous Lesions Depends on Anatomic Localization: Planar Bone Scintigraphy Versus 18F PET. J Nucl Med 1999 Oct;40(40): Schirrmeister H, et.al. Early Detection and Accurate Description of Extent of Metastatic Bone Disease in Breast Cancer with Fluoride Ion and Positron Emission Tomography. J Clin Oncol 1999 August ;17(8): Petren-Mallmin M, et.al. Skeletal Metastases From Breast Cancer: Uptake of 18F-Fluoride Measured with PET in Correlation with CT. Skeletal Radiol 1998;27: Minerich, SM. 18F Sodium Fluoride Bone PET and PET/CT: Technical Tips. SNMTS Uptake 2009 Sept/Oct; 15(5):2, Drug Safety and Availability: U.S. Food & Drug Administration; Available at: Accessed: December 8, CancerWeb Project (U of Newcastle-New Tyne): Medical Dictionary; Available at: Accessed: Jun 7, Bone Tumor Information; Henry DeGroot III, M.D., Principal Author; Avaliable at: Accessed December 15, National Cancer Institute Dictionary of Cancer Terms; National Institutes of Health; Available at: Accessed: December 8, Glossary of Terms: Skeletal Wellness Institute for Cancer; Available at: Accessed: December 16, Encyclopedia of Medical Imaging; GE Healthcare; 2009; Available at: Accessed December 16, Nuclear Medicine Information; RadiologyInfo; American College of Radiology, Radiological Society of North America; Available at: www. radiology.info.org; Accessed: December 17, MedLinePlus Online Medical Dictionary; U.S. National Library of Medicine; National Institutes of Health; Available at: medlineplus/mplusdictionary.html; Accessed: Sept 28,
12 Quality + Confidence = Outcomes IBA Molecular believes that personalized medicine lies in the scientifi c equation, Q+C=O, which symbolizes Quality + Confidence = Outcomes. Our reputation for delivering quality products, together with our comprehensive educational offerings enables you to increase confidence in your imaging staff, expanding the impact of nuclear medicine on patient care and outcomes. IBA Molecular North America, Inc Atlantic Blvd., Suite 730 Dulles, VA Toll Free: Tel.: Fax IBA Molecular North America, Inc. April 2010 F-18 NaF Reference Booklet 001 IBA 2010 / All Rights Reserved. IBA Molecular Jan 2010 Bone Campaign 001 IBA 2010 / All Rights Reserved This brochure has been printed on environment-friendly paper using soy based inks. marketing_us@iba-group.com Copyright IBA This information is provided courtesy of IBA Molecular North America, Inc. IBA is a registered trademark of IBA SA. Any opinions, fi ndings and conclusions or recommendations expressed in this material are those of the author. The information is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health condition or a disease and is not a substitute for professional medical care.
Using PET/CT in Prostate Cancer
Using PET/CT in Prostate Cancer Legal Disclaimer These materials were prepared in good faith by MITA as a service to the profession and are believed to be reliable based on current scientific literature.
More informationJoint Comments on Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer (CAG-00065R1)
July 2, 2009 Tamara Syrek Jensen, J.D. Acting Director, Coverage and Analysis Group Centers for Medicare & Medicaid Services 7500 Security Blvd., Mail Stop C1-09-06 Baltimore, MD 21244 Re: Joint Comments
More informationF NaF PET/CT in the Evaluation of Skeletal Malignancy
F NaF PET/CT in the Evaluation of Skeletal Malignancy Andrei Iagaru, MD September 26, 2013 School of of Medicine Ø Introduction Ø F NaF PET/CT in Primary Bone Cancers Ø F NaF PET/CT in Bone Metastases
More informationQuestions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss. A Publication of The Bone and Cancer Foundation
Questions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss A Publication of The Bone and Cancer Foundation Contents This publication includes important information about
More informationWhole body F-18 sodium fluoride PET/CT in the detection of bone metastases in patients with known malignancies: A pictorial review
Whole body F-18 sodium fluoride PET/CT in the detection of bone metastases in patients with known malignancies: A pictorial review Poster No.: C-1196 Congress: ECR 2014 Type: Educational Exhibit Authors:
More informationColorectal Cancer Treatment
Scan for mobile link. Colorectal Cancer Treatment Colorectal cancer overview Colorectal cancer, also called large bowel cancer, is the term used to describe malignant tumors found in the colon and rectum.
More informationWhat Lung Cancer Patients Need to Know About Bone Health. A Publication of The Bone and Cancer Foundation
What Lung Cancer Patients Need to Know About Bone Health A Publication of The Bone and Cancer Foundation Contents THIS PUBLICATION PROVIDES IMPORTANT INFORMATION ABOUT THE RELATIONSHIP BETWEEN LUNG CANCER
More informationBrain Tumors. What is a brain tumor?
Scan for mobile link. Brain Tumors A brain tumor is a collection of abnormal cells that grows in or around the brain. It poses a risk to the healthy brain by either invading or destroying normal brain
More informationNuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique
Nuclear Medicine - Unsealed radioactive preparations the tracer mixes with the patients body fluids on a molecular level (e.g. after intravenous injection) - 3 main fields: - In vitro : measuring concentrations
More informationAustin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF)
Austin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF) Overview Indication Sodium Fluoride F18 injection is a radioactive diagnostic agent for positron emission
More informationBone Metastases. Sukanda Denjanta, M.Sc., BCOP Pharmacy Department, Chiangrai Prachanukroh Hospital
Bone Metastases Sukanda Denjanta, M.Sc., BCOP Pharmacy Department, Chiangrai Prachanukroh Hospital 1 Outline Pathophysiology Signs & Symptoms Diagnosis Treatment Spinal Cord Compression 2 General Information
More informationFREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS The following questions are representative of questions that patients and family members ask when they visit the Bone and Cancer Foundation website or contact the Foundation
More informationAustin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate)
Austin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate) Overview Ga-68 dotatate binds to somatostatin receptors, with highest affinity for subtype 2 receptors (sstr2). It binds to cells that express
More informationPalliative treatment of bone metastases with samarium-153
APPROVED BY: Z. Yang Page 1 of 5 Palliative treatment of bone metastases with samarium-153 Primary Indications: Rationale: To treat bone pain resulting from osteoblastic metastases as defined by bone scan.
More informationQuestions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss. A Publication of The Bone and Cancer Foundation
Questions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss A Publication of The Bone and Cancer Foundation Contents This publication includes important information about
More informationSodium Fluoride F 18 Injection* PET/CT Imaging
Sodium Fluoride F 18 Injection* PET/CT Imaging for Prostate Cancer Sodium Fluoride F 18 Injection* ( 18 F NaF) PET/CT Imaging of Bone Metastases in Prostate Cancer About Prostate Cancer According to the
More informationGLOSSARY. This glossary includes definitions for patients who have cancer with bone involvement. New definitions will be added periodically.
GLOSSARY This glossary includes definitions for patients who have cancer with bone involvement. New definitions will be added periodically. For more in-depth information, please refer to the Bone and Cancer
More informationProstate Cancer Basics: Background Information for Outreach Activities with Oncologists, Urologists and Surgeons
Prostate Cancer Basics: Background Information for Outreach Activities with Oncologists, Urologists and Surgeons Legal Disclaimer These materials were prepared in good faith by MITA as a service to the
More informationManaging Bone Pain in Metastatic Disease. Rachel Schacht PA-C Medical Oncology and Hematology Associates Presented on 11/2/2018
Managing Bone Pain in Metastatic Disease Rachel Schacht PA-C Medical Oncology and Hematology Associates Presented on 11/2/2018 None Disclosures Managing Bone Pain in Metastatic Disease This lecture will
More informationCase 4: Disseminated bone metastases from differentiated follicular thyroid cancer
Case 4: Disseminated bone metastases from differentiated follicular thyroid cancer Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa (Italy) Disseminated bone
More informationWhole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging
Whole Body MRI Prostate Cancer recurrence, progression and restaging Dr. Nina Tunariu Consultant Radiology Drug Development Unit and Prostate Targeted Therapies Group 12-13 Janeiro 2018 Evolving Treatment
More informationBreast Cancer. What is breast cancer?
Scan for mobile link. Breast Cancer Breast cancer is a malignant tumor in or around breast tissue. It usually begins as a lump or calcium deposit that develops from abnormal cell growth. Most breast lumps
More informationAustin Radiological Association Nuclear Medicine Procedure BONE MINERAL STUDY (Tc-99m-MDP, Tc-99m-HMDP)
Austin Radiological Association Nuclear Medicine Procedure BONE MINERAL STUDY (Tc-99m-MDP, Tc-99m-HMDP) Overview The Bone Mineral Study, with either Tc-99m-MDP or Tc-99m-HMDP, depicts the distribution
More informationBreast Cancer. What is breast cancer?
Scan for mobile link. Breast Cancer Breast cancer is a malignant tumor in or around breast tissue. It usually begins as a lump or calcium deposit that develops from abnormal cell growth. Most breast lumps
More informationPancreatic Cancer. What is pancreatic cancer?
Scan for mobile link. Pancreatic Cancer Pancreatic cancer is a tumor of the pancreas, an organ that is located behind the stomach in the abdomen. Pancreatic cancer does not always cause symptoms until
More informationFIRST COAST SERVICE OPTIONS FLORIDA MEDICARE PART B LOCAL COVERAGE DETERMINATION
FIRST COAST SERVICE OPTIONS FLORIDA MEDICARE PART B LOCAL COVERAGE DETERMINATION CPT/HCPCS Codes 78300 Bone and/or joint imaging; limited area 78305 multiple areas 78306 whole body 78315 three phase study
More informationHead and Neck Cancer Treatment
Scan for mobile link. Head and Neck Cancer Treatment Head and neck cancer overview The way a particular head and neck cancer behaves depends on the site in which it arises (the primary site). For example,
More informationGeneral information about prostate cancer
Prostate Cancer General information about prostate cancer Key points Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate. Signs of prostate cancer include
More information1 Introduction. 2 Materials and methods. LI Na 1 LI Yaming 1,* YANG Chunming 2 LI Xuena 1 YIN Yafu 1 ZHOU Jiumao 1
Nuclear Science and Techniques 20 (2009) 354 358 18 F-FDG PET/CT in diagnosis of skeletal metastases LI Na 1 LI Yaming 1,* YANG Chunming 2 LI Xuena 1 YIN Yafu 1 ZHOU Jiumao 1 1 Department of Nuclear Medicine,
More informationOption D: Medicinal Chemistry
Option D: Medicinal Chemistry Basics - unstable radioactive nuclei emit radiation in the form of smaller particles alpha, beta, positron, proton, neutron, & gamma are all used in nuclear medicine unstable
More informationBone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors
Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors Lars Stegger, Benjamin Noto Department of Nuclear Medicine University Hospital Münster, Germany Content From PET to
More informationBrain Tumor Treatment
Scan for mobile link. Brain Tumor Treatment Brain Tumors Overview A brain tumor is a group of abnormal cells that grows in or around the brain. Tumors can directly destroy healthy brain cells. They can
More informationCancer , The Patient Education Institute, Inc. ocf80101 Last reviewed: 06/08/2016 1
Cancer Introduction Cancer begins in your cells, which are the building blocks of your body. Extra cells can form a mass called a tumor. Some tumors aren t cancerous, while other ones are. Cells from cancerous
More informationPET-MRI in malignant bone tumours. Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany
PET-MRI in malignant bone tumours Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany Content From PET to PET/MRI General considerations Bone metastases Primary bone tumours
More informationPOSITRON EMISSION TOMOGRAPHY (PET)
Status Active Medical and Behavioral Health Policy Section: Radiology Policy Number: V-27 Effective Date: 08/27/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members should
More informationINDICATIONS AND USAGE
1. INDICATIONS AND USAGE a) Axumin is indicated for positron emission tomography (PET) in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen (PSA) levels following
More informationLymphoma is a cancer that develops in the white blood cells (lymphocytes) of the lymphatic system, which is part of the body's immune system.
Scan for mobile link. Lymphoma Lymphoma is a cancer that develops in the white blood cells of the lymphatic system. Symptoms may include enlarged lymph nodes, unexplained weight loss, fatigue, night sweats
More informationEsophageal cancer. What is esophageal cancer? Esophageal cancer is a disease in which malignant (cancer) cells form in the tissues of the esophagus.
Esophageal Cancer Esophageal cancer What is esophageal cancer? What are risk factors? Signs and symptoms Tests for esophageal cancer Stages of esophageal cancer Treatment options What is esophageal cancer?
More informationSmall Cell Lung Cancer
Small Cell Lung Cancer Small cell lung cancer (SCLC) affects 15% of all lung cancer patients. SCLC is the most aggressive type of lung cancer. It may be treated with chemotherapy and radiation. SCLC has
More informationNuclear Medicine and PET. D. J. McMahon rev cewood
Nuclear Medicine and PET D. J. McMahon 150504 rev cewood 2018-02-15 Key Points Nuclear Medicine and PET: Imaging: Understand how Nuc Med & PET differ from Radiography & CT by the source of radiation. Be
More informationAcute: Symptoms that start and worsen quickly but do not last over a long period of time.
Cancer Glossary Acute: Symptoms that start and worsen quickly but do not last over a long period of time. Adjuvant therapy: Treatment given after the main treatment. It usually refers to chemotherapy,
More informationMolecular Imaging and Breast Cancer
Molecular Imaging and Breast Cancer Breast cancer forms in tissues of the breast usually in the ducts, tubes that carry milk to the nipple, and lobules, the glands that make milk. It occurs in both men
More informationPancreatic Cancer Treatment
Scan for mobile link. Pancreatic Cancer Treatment What is pancreatic cancer? Pancreatic cancer begins in the pancreas, an organ located deep in the abdomen behind the stomach. The pancreas releases hormones
More informationTypical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located?
Typical PET Image Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located? PET/CT Oncology Imaging Anatometabolic fusion images are useful in the management
More informationGeneral Nuclear Medicine
General Nuclear Medicine What is General Nuclear Medicine? What are some common uses of the procedure? How should I prepare? What does the equipment look like? How does the procedure work? How is the procedure
More informationNuclear Medicine Bone Imaging
Nuclear Medicine Bone Imaging An Introductory Guide For Patients And Their Families You may be wondering why your doctor ordered a nuclear medicine bone scan. You might have questions such as: How does
More informationImaging of bone metastases
Imaging of bone metastases Antoine Feydy Service de Radiologie B Hôpital Cochin APHP Université Paris Descartes antoine.feydy@aphp.fr MEXICO 2016 INTRODUCTION Diagnostic Imaging Imaging Modalities Strengths,
More informationOncology 101. Cancer Basics
Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases
More informationCervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix.
Cervical Cancer Cervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix. The cervix is the lower, narrow end of the uterus (the hollow, pear-shaped organ where
More informationProstate Cancer and PSMA:
Prostate Cancer and PSMA: The Clinical Perspective from Liverpool. Dr. Christopher Mayes. Professor Sobhan Vinjamuri. Department of Nuclear Medicine Royal Liverpool University Hospital (BSUR 2016 Plymouth)
More informationEsophageal Cancer. What is esophageal cancer?
Scan for mobile link. Esophageal Cancer Esophageal cancer occurs when cancer cells develop in the esophagus. The two main types are squamous cell carcinoma and adenocarcinoma. Esophageal cancer may not
More informationMolecular Imaging of Bone Metastasis Hojjat Ahmadzadehfar
Molecular Imaging of Bone Metastasis Hojjat Ahmadzadehfar Seite 1 Bone metastases Different tumors % 80 70 68% 73% 60 50 40 40% 35% 42% 36% 30 20 10 0 5% prostate bladder renal breast thyroid lung GI urological
More informationDenominator Criteria (Eligible Cases): Patient encounter during the performance period (CPT): 78300, 78305, 78306, 78315, 78320
Quality ID #147: Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS
More informationPET ID: [<P4T> However, if sheet says PCT, then old scanner was used, change to PCT] [number]
SYNGO PET codes 870 CT EXAMINATION: TUMOR FDG-PET/CT IMAGING PET ID: [ However, if sheet says PCT, then old scanner was used, change to PCT] [number] HISTORY: [ ] The study is requested for [ insert
More informationHybrid bone scintigraphy in gastrointestinal malignancies Institutional Experience
Hybrid bone scintigraphy in gastrointestinal malignancies Institutional Experience Nazia Rashid 1, Saima Riaz 1, Humayun Bashir 1, Shafqat Mehmood 2 1 Nuclear Medicine Department ad 2 Internal Medicine
More informationRe: Comments on Proposed Decision Memorandum (CAG-00065R2) Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer
1300 North 17 th Street Suite 900 Arlington, Virginia 22209 Tel: 703.841.3200 Fax: 703.841.3392 www.medicalimaging.org October 15, 2015 CAGInquiries@cms.hhs.gov Tamara Syrek Jensen, Esq. Director, Coverage
More informationNuclear Medicine in the Diabetic Foot
26.11.2015, Uniklinik Balgrist Nuclear Medicine in the Diabetic Foot Martin Hüllner Nuklearmedizin und Neuroradiologie, USZ / UZH Outline A. Imaging modalities brief technical overview B. Nuclear medicine
More informationMolecular Imaging and Cancer
Molecular Imaging and Cancer Cancer causes one in every four deaths in the United States, second only to heart disease. According to the U.S. Department of Health and Human Services, more than 512,000
More informationProstate Case Scenario 1
Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has
More informationElderly men with prostate cancer + ADT
Elderly men with prostate cancer + ADT Background and Rationale ADT and Osteoporosis Proportion of Patients With Fractures 1-5 Yrs After Cancer Diagnosis 21 18 +6.8%; P
More informationVaginal cancer: Know what to expect
Vaginal cancer: Know what to expect For women with vaginal cancer What is the vagina? The vagina is a hollow canal that connects the cervix and the uterus to the outside. of the body. When a woman gives
More informationRadiopharmacy. Prof. Dr. Çetin ÖNSEL. CTF Nükleer Tıp Anabilim Dalı
Prof. Dr. Çetin ÖNSEL CTF Nükleer Tıp Anabilim Dalı What is Nuclear Medicine? Nuclear Medicine is the branch of medicine concerned with the use of radionuclides in the study and the diagnosis of diseases.
More informationDoes PET/CT Have an Additional Value in Detection of Osteolytic Bone Metastases.
Egyptian J. Nucl. Med., Vol 2, No. 2, Dec. 2009 65 ONCOLOGY, Original Article Does PET/CT Have an Additional Value in Detection of Osteolytic Bone Metastases. R. Riad, M.D.*, M. Awad, M.D. **, E. Eldebawy,
More informationSuspecting Tumors, or Could it be cancer?
Suspecting Tumors, or Could it be cancer? Donna E. Reece, M.D. Princess Margaret Cancer Centre University Health Network Toronto, ON CANADA 07 February 2018 Background Low back pain is common However,
More informationAnemia: A condition in which the number of red blood cells is below normal.
Veterinary Teaching Hospital Oncology Service Virginia-Maryland Regional College of Veterinary Medicine 245 Duck Pond Drive Blacksburg, VA 24061 Phone: 540-231-4621 Definitions This fact sheet is based
More informationChildren's (Pediatric) Nuclear Medicine
Scan for mobile link. Children's (Pediatric) Nuclear Medicine Children s (pediatric) nuclear medicine imaging uses small amounts of radioactive materials called radiotracers, a special camera and a computer
More informationGeneral Nuclear Medicine
Scan for mobile link. General Nuclear Medicine Nuclear medicine imaging uses small amounts of radioactive materials called radiotracers that are typically injected into the bloodstream, inhaled or swallowed.
More informationLymphoscintigraphy is a special type of nuclear medicine imaging that provides pictures called scintigrams of the lymphatic system.
Scan for mobile link. Lymphoscintigraphy Lymphoscintigraphy helps evaluate your body s lymphatic system for disease using small amounts of radioactive materials called radiotracers that are typically injected
More informationHEALTHFIRST 2011 RADIOLOGY PROGRAM CODE LIST
HEALTHFIRST 2011 RADIOLOGY PROGRAM CODE LIST Outpatient Radiology utilization call Carecore at 1-877-773-6964 Modality CPT CODE Description CT SCANS 70450 CT HEAD/BRAIN W/O CONTRAST CT SCANS 70460 CT HEAD/BRAIN
More informationCurrent Management of Metastatic Bone Disease
Current Management of Metastatic Bone Disease Evaluation and Medical Management Dr. Sara Rask Head, Medical Oncology Simcoe Muskoka Regional Cancer Centre www.rvh.on.ca Objectives 1. Outline an initial
More informationPositron Emission Tomography Computed Tomography (PET/CT)
Positron Emission Tomography Computed Tomography (PET/CT) What is Positron Emission Tomography Computed Tomography (PET/CT) Scanning? What are some common uses of the procedure? How should I prepare for
More informationTransarterial Chemoembolisation (TACE) with Drug-Eluting Beads
Transarterial Chemoembolisation (TACE) with Drug-Eluting Beads A minimally invasive treatment for liver cancer Provided as an educational service by Biocompatibles UK Ltd, a BTG International group company
More informationWhat is Thyroid Cancer? Here are four types of thyroid cancer:
What is Thyroid Cancer? Thyroid cancer is a group of malignant tumors that originate from the thyroid gland. The thyroid is a gland in the front of the neck. The thyroid gland absorbs iodine from the bloodstream
More informationRyan Niederkohr, M.D. Slides are not to be reproduced without permission of author
Ryan Niederkohr, M.D. CMS: PET/CT CPT CODES 78814 Limited Area (e.g., head/neck only; chest only) 78815 78816 Regional (skull base to mid-thighs) True Whole Body (skull vertex to feet) SELECTING FIELD
More informationLu 177-Dotatate (Lutathera) Therapy Information
Lu 177-Dotatate (Lutathera) Therapy Information Information for Lu 177-dotatate therapy also known as Lutathera, for the treatment of metastatic midgut neuroendocrine tumor and other metastatic neuroendocrine
More informationLouisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust
Louisa Fleure Advanced Prostate Cancer Clinical Nurse Specialist Guys and St Thomas NHS Trust The classification of advanced prostate cancer The incidence of patients presenting with, or developing advanced
More informationNational Oncologic PET Registry (NOPR) F-18 Fluoride PET Case Report Forms
Form (NOPR) F-18 Fluoride PET Case Report Forms Version Date Patient Information Sheet 06/17/10 (Spanish translation available at: http://www.cancerpetregistry.org/pdf/patient_info_spanish.pdf) Interpreting
More informationNuclear Medicine Head and Neck Region. Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine
Nuclear Medicine Head and Neck Region Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine Thyroid scintigraphy Parathyroid scintigraphy F18-FDG PET examinations in head and neck cancer
More informationUnusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma
49 Unusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma Loredana Miglietta a Maria Angela Parodi b Luciano Canobbio b Luca Anselmi c a Medical
More informationPET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET
Positron Emission Tomography (PET) When calling Anthem (1-800-533-1120) or using the Point of Care authorization system for a Health Service Review, the following clinical information may be needed to
More informationGastric (Stomach) Cancer
Gastric (Stomach) Cancer Gastric cancer is a disease in which malignant (cancer) cells form in the lining of the stomach. The stomach is a J-shaped organ in the upper abdomen. It is part of the digestive
More informationLouisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust
Louisa Fleure Advanced Prostate Cancer Clinical Nurse Specialist Guys and St Thomas NHS Trust The classification of advanced prostate cancer The incidence of patients presenting with, or developing advanced
More informationMetastatic Disease of the Proximal Femur
CASE REPORT Metastatic Disease of the Proximal Femur WI Faisham, M.Med{Ortho)*, W Zulmi, M.S{Ortho)*, B M Biswal, MBBS** 'Department of Orthopaedic, "Department of Oncology and Radiotherapy, School of
More informationOvarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors
Ovarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors Overview Ovarian epithelial cancer, fallopian tube cancer, and primary peritoneal cancer are
More informationFDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave
FDG PET/CT STAGING OF LUNG CANCER Dr Shakher Ramdave FDG PET/CT STAGING OF LUNG CANCER FDG PET/CT is used in all patients with lung cancer who are considered for curative treatment to exclude occult disease.
More informationHigh Tech Imaging Quick Reference Guide
High Tech Imaging Quick Reference Guide 1 High Tech Imaging Authorizations may now be requested through our secure provider portal, BlueAccess. Getting Started Step 1: Log into BlueAccess from www.bcbst.com
More informationORIGINAL ARTICLE ABSTRACT
ORIGINAL ARTICLE 99m Tc MDP Bone Scan in Lung Cancer: Predilection Sites for Metastasis Shamim M F Begum, Zeenat Jabin, Rahima Perveen, Nasreen Sultana, Laila S Banu National Institute of Nuclear Medicine
More informationPatient Information. Prostate Tissue Ablation. High Intensity Focused Ultrasound for
High Intensity Focused Ultrasound for Prostate Tissue Ablation Patient Information CAUTION: Federal law restricts this device to sell by or on the order of a physician CONTENT Introduction... 3 The prostate...
More informationRADIONUCLIDE THERAPY FOR PALLIATION OF PAIN FROM BONY METASTASES
RADIONUCLIDE THERAPY FOR PALLIATION OF PAIN FROM BONY METASTASES Overview and Topics to Be Covered Reviews the use of radionuclide therapy in nuclear medicine for palliation of pain due to bony metastases.
More informationAtlas of Bone Scintigraphy in the Developing Paediatric Skeleton. The Normal Skeleton, Variants and Pitfalls
Atlas of Bone Scintigraphy in the Developing Paediatric Skeleton The Normal Skeleton, Variants and Pitfalls FOREWORD Since the introduction of Technetium 99m polyphosphate in 1972 by Dr. M. Subramanian,
More informationUnderstanding bone metastases and XGEVA
Understanding bone metastases and XGEVA Contents About bone metastases 3 About XGEVA 5 Dealing with common side effects of XGEVA 8 FAs about living with bone metastases 9 Notes 10 About bone metastases
More informationClinical indications for positron emission tomography
Clinical indications for positron emission tomography Oncology applications Brain and spinal cord Parotid Suspected tumour recurrence when anatomical imaging is difficult or equivocal and management will
More informationMolecular Imaging and the Brain
Molecular imaging technologies are playing an important role in neuroimaging, a branch of medical imaging, by providing a window into the living brain. Where CT and conventional MR imaging provide important
More informationNuclear Medicine - Hepatobiliary
Scan for mobile link. Nuclear Medicine - Hepatobiliary Hepatobiliary nuclear medicine imaging helps evaluate the parts of the biliary system, including the liver, gallbladder and bile ducts, using small
More informationLung Cancer Treatment
Scan for mobile link. Lung Cancer Treatment Lung cancer overview More than one in four of all diagnosed cancers involve the lung, and lung cancer remains the most common cancer-related cause of death among
More informationThe management and treatment options for secondary bone disease. Omi Parikh July 2013
The management and treatment options for secondary bone disease Omi Parikh July 2013 Learning Objectives: The assessment and diagnostic process of patients with suspected bone metastases e.g bone scan,
More informationPositron Emission Tomography - Computed Tomography (PET/CT)
Scan for mobile link. Positron Emission Tomography - Computed Tomography (PET/CT) Positron emission tomography (PET) uses small amounts of radioactive materials called radiotracers, a special camera and
More informationBone and CT Scans Are Complementary for Diagnoses of Bone Metastases in Breast Cancer When PET Scans Findings Are Equivocal: A Case Report
Bone and CT Scans Are Complementary for Diagnoses of Bone Metastases in Breast Cancer When Scans Findings Are Equivocal: A Case Report Yuk-Wah Tsang 1, Jyh-Gang Leu 2, Yen-Kung Chen 3, Kwan-Hwa Chi 1,4
More informationWhat Is Nuclear Medicine?
What Is Nuclear Medicine? An Introductory Guide For Patients And Their Families What is nuclear medicine? Nuclear medicine is a type of medical imaging that uses small amounts of radioactive material (called
More informationCervical Cancer. Introduction Cervical cancer is a very common cancer. Nearly one half million cases are diagnosed worldwide each year.
Cervical Cancer Introduction Cervical cancer is a very common cancer. Nearly one half million cases are diagnosed worldwide each year. Most cases of cervical cancer can be prevented by getting regular
More information